Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eltoprazine for Cognitive Impairment in Schizophrenia
NCT01266174Phase 2Completed
- Sponsor
- Amarantus BioScience
- Start
- Aug 2011
- Primary completion
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of eltoprazine in schizophrenia, sponsored by Amarantus BioScience. Started Aug 2011; status: completed.
02
Drugs
eltoprazine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT01266174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01266174.